Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Health Catalyst (HCAT) EBIAT (2018 - 2025)

Health Catalyst's EBIAT history spans 8 years, with the latest figure at -$91.0 million for Q4 2025.

  • For Q4 2025, EBIAT fell 340.31% year-over-year to -$91.0 million; the TTM value through Dec 2025 reached -$178.0 million, down 156.07%, while the annual FY2025 figure was -$178.0 million, 156.07% down from the prior year.
  • EBIAT reached -$91.0 million in Q4 2025 per HCAT's latest filing, down from -$22.2 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$13.5 million in Q2 2024 to a low of -$91.0 million in Q4 2025.
  • Average EBIAT over 5 years is -$32.8 million, with a median of -$31.5 million recorded in 2023.
  • Peak YoY movement for EBIAT: surged 58.56% in 2024, then crashed 340.31% in 2025.
  • A 5-year view of EBIAT shows it stood at -$49.0 million in 2021, then increased by 26.96% to -$35.8 million in 2022, then grew by 15.29% to -$30.3 million in 2023, then soared by 31.8% to -$20.7 million in 2024, then plummeted by 340.31% to -$91.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's EBIAT are -$91.0 million (Q4 2025), -$22.2 million (Q3 2025), and -$41.0 million (Q2 2025).